Bringing the fundamentals into focus…
Back to Revolution Medicines, Inc.
How Revolution Medicines, Inc. stacks up
RVMD · against 70 other Healthcare companies of similar size
Overall
34/ 100
Near the bottom of its peers.
Ranked #65 of 71 · scores higher than 9% of peers
Bars: peers in each 10-point band of the overall score6 peers with an overall score of 30–39, including RVMD · Click a bar to see the companies
The four scores behind it
Overall = average of valuation, growth, profitability and safety percentile (categories without data are skipped)Ranking by overall score
Top 5 and the companies ranked around RVMD| Rank | Company | Market cap | Overall | Valuation | Growth | Profitability | Risk |
|---|---|---|---|---|---|---|---|
| 1 | 23.8B USD | 84 | 82 | 82 | 98 | 0 / 2 | |
| 2 | 56.7B USD | 79 | 42 | 96 | 93 | 0 / 2 | |
| 3 | 193.6B HKD (≈$24.8B) | 78 | 64 | 74 | 97 | 0 / 2 | |
| 4 | 4.61T JPY (≈$31.3B) | 76 | 93 | 89 | 87 | 1 / 2 | |
| 5 | 534.1B HKD (≈$68.4B) | 75 | 72 | 76 | 96 | 1 / 2 | |
| 61 | 154.4B BRL (≈$27.8B) | 43 | 69 | 28 | 53 | 2 / 2 | |
| 61 | 272.9B BRL (≈$49.1B) | 43 | 54 | 44 | 67 | 2 / 2 | |
| 63 | 56.0B USD | 39 | 8 | 86 | 26 | 1 / 2 | |
| 64 | 22.8B USD | 38 | 8 | 95 | 14 | 1 / 2 | |
| 65 | 41.6B USD | 34 | 8 | — | 14 | 0 / 2 | |
| 66 | 21.8B USD | 32 | 8 | 18 | 24 | 0 / 2 | |
| 66 | 21.7B USD | 32 | 52 | 26 | 31 | 2 / 2 | |
| 68 | 66.3B USD | 30 | 44 | 20 | 37 | 2 / 2 | |
| 69 | 26.0B USD | 28 | 8 | 5 | 6 | 0 / 2 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score